Benzinga | Nov 3, 2021 09:17AM EDT

Barclays Maintains Equal-Weight on Amgen, Lowers Price Target to $228

Barclays analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $230 to $228.